Clinical trial
Contrast-Enhanced Mammography (CEM) in the Evaluation of Cancer of Unknown Primary Syndrome (CUP): A Multicentric Observational Study
NCT06843096 is registered in ClinicalTrials.gov with Graziella di Grezia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Contrast-Enhanced Mammography (CEM) in the Evaluation of Cancer of Unknown Primary Syndrome (CUP): A Multicentric Observational Study
- Lead sponsor
- Graziella di Grezia
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 1, 2025
- Completion date
- January 31, 2026
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer diagnosis, breast cancer prevention